Ofer Ben-Noon’s billion-dollar journey to Palo Alto Networks: Mentored by Zohar Zisapel

Ofer Ben-Noon’s billion-dollar journey to Palo Alto Networks: Mentored by Zohar Zisapel. At 38, entrepreneur Ofer Ben-Noon already has two exits worth more than a billion dollars, including the sale of Talon to Palo Alto Networks at the height of the war. In a candid interview, he shares his close relationship with the late Israeli high-tech pioneer Zohar Zisapel, who became a father figure and transformed him from a "talented entrepreneur to a successful one."

Immunai signs $18M collaboration with AstraZeneca to make cancer drug trials more efficient. The collaboration will focus on clinical decision-making, including dose selection, elucidating mechanisms of action, patient responder vs. non-responder analysis, and biomarker identification, by leveraging the Israeli biotech unicorn’s AI model of the immune system.

New Check Point CEO Nadav Zafrir to receive $15 million in first year. Check Point moves away from Gil Shwed’s equity-based model with Zafrir’s mixed compensation plan.

Zoomin’s journey from bootstrapped startup to Salesforce’s AI arsenal. What started as a quiet Israeli company is now reshaping customer service with AI.

"Artificial intelligence is the Fourth Industrial Revolution." Rotem Shacham, a director at PSG Equity, described the methodology she developed to identify the highest quality AI startups.